Dermatology News and Research

Latest Dermatology News and Research

3M granted FDA approval for cream to treat superficial basal cell carcinoma

3M announced today that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of nonmelanoma skin cancer.

16 Jul 2004

Sunscreen to protect the skin's genetic material, or DNA

A new company, DNAcare Systems, is to be formed at the University of Newcastle upon Tyne, based on research by skin cancer expert Dr Mark Birch-Machin and colleagues.

8 Jul 2004

UV exposure from sun tanning beds leads to pain relief and euphoric feelings

Frequent tanning bed users may be getting more out of the experience than darker skin. Researchers at Wake Forest University Baptist Medical Center say exposure to ultraviolet light may produce a “relaxing” effect that lures tanners back to the beds.

7 Jul 2004

New medical imaging equipment provides early detection of skin cancer

Could You Have Skin Cancer? Do you know if you have skin cancer or if you have skin lesions that could develop into skin cancer? Early detection of these ticking time bombs enhances survival.

From Siemens Healthineers 28 Jun 2004

Hair cloning could be the cure for baldness

Researcher Kevin McElwee -- one of only a few people in the world who hold a doctoral degree in hair biology -- thinks a cure for baldness that uses the technique of hair cloning could be commercially available within 10 years.

24 Jun 2004

Cost differences of methotrexate and cyclosporine to treat psoriasis neglible

The difference in cost associated with using two common treatments for psoriasis over the course of one year with treatment lasting 16 weeks are small.

21 Jun 2004

Pulsed dye laser therapy not effective in treating acne

Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.

16 Jun 2004

Over-the-counter cream protects against jellyfish stings

Two dozen volunteers bravely exposed their arms to jellyfish tentacles as part of a new Stanford University School of Medicine study to test a topical, over-the-counter cream designed to protect against stinging nettles. Fortunately for the volunteers, the cream appeared to be relatively effective.

3 Jun 2004

Connetics issued U.S. patent for emollient-foam technology

Connetics Corporation, a specialty pharmaceutical company that develops and commercializes dermatology products, announced today that on May 4, 2004 the United States Patent and Trademark Office (USPTO) issued to Connetics Patent No. 6,730,288 B1. The patent has 7 independent product claims, and covers a pharmaceutical aerosol foam composition having occlusive capability.

17 May 2004

Five million village doctors in rural China to be re-trained

A memorandum which is to lead to the re-training of five million village doctors in rural China is to be signed on 23 May in Beijing, China. The memorandum goes back to the initiative of Terence Ryan, Professor of Dermatology at the University of Oxford, who has been instrumental in drawing it up and will participate in the signing.

14 May 2004

Misconceptions lead to late diagnosis of melanoma in African Americans

Susan C. Taylor, M.D., assistant clinical professor of dermatology, The College of Physicians and Surgeons, Columbia University in New York, addressed the alarming statistics that support the fact that prevention and detection messages about melanoma are not being heeded by African Americans.

3 May 2004

Teenagers ignore warnings on skin cancer

For most teens, getting a tan during spring break or in preparation for the prom is as common as these rites of passage themselves. Although teens hear dermatologists’ warnings that tanning is the most avoidable risk factor in the prevention of skin cancer, studies find they forgo this advice in favor of the bronzed look.

3 May 2004

FDA approves new drug Enbrel for psoriasis

The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.

1 May 2004

UK, skin cancer specialists to check out moles

Macmillan skin cancer nurse, Denise Hancock, and colleagues from the Dermatology Department at Southampton University Hospitals Trust are inviting members of the public to 'check out their moles' at a Mole Watch Day in Marks and Spencer in West Quay on Wednesday 12 May, from 9am-5pm.

30 Apr 2004

Study of an oral fumarate shows improvement in psoriasis

Biogen Idec and Fumapharm AG today announced results from a Phase II study of BG-12, an oral fumarate, in patients with severe psoriasis.

29 Apr 2004

Psoriasis medications can treat more than the skin

The National Psoriasis Foundation, Dermatology Nurses Association, Dermatologists and People with Psoriasis have collaborated to offer a new resource to help people with psoriasis cope with the social and emotional impact of psoriasis.

27 Apr 2004

First generic cultivate(R) cream to receive tentative FDA approval

Atrix Laboratories, Inc. announced today the company received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for fluticasone propionate cream, 0.05%.

27 Apr 2004

Helix BioMedix announces positive results of comparative product anti-wrinkle study

Helix BioMedix today announced that it has completed a 12-week consumer product test comparing the company's anti-wrinkle peptide, HB168 with Renova(R), a currently marketed FDA approved product.

27 Apr 2004

Statement on patient safety principles for office-based surgery

Over the past few years, there has been a noticeable increase in the number of invasive procedures being performed in the office setting. Recognizing that many states still haven't issued patient safety guidelines in this area, the American College of Surgeons (ACS) sponsored a resolution, which was passed at the American Medical Association's (AMA's) December 2002 Interim Meeting of its House of Delegates.

22 Apr 2004

Protein kinase complex influences the outer layer of skin to control the eventual shape of the full-grown skeleton and skull

Continuing studies about an important regulatory protein kinase complex called I-kappa-B kinase (or IKK) have now shown that a subunit of IKK – IKK alpha – influences the outer layer of skin in developing mice to control the eventual shape of the full-grown skeleton and skull.

7 Apr 2004